Ionis Pharmaceuticals, Inc. - IONS

SEC FilingsOur IONS Tweets

About Gravity Analytica

Recent News

  • 11.11.2025 - Webcast from AHA to Discuss Olezarsen CORE and CORE2 Data
  • 10.07.2025 - Innovation Day 2025
  • 10.07.2025 - Innovation Day 2025
  • 09.12.2025 - Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases
  • 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.09.2025 - Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
  • 09.08.2025 - Ionis to host investors and analysts for Innovation Day 2025
  • 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.04.2025 - 2025 Wells Fargo Healthcare Conference

Recent Filings

  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities